insights_auto
Outlook: 29.7% bullish·8.1% bearish
Go to analysischevron_right
NVO:NYSE
Novo Nordisk A/S
38,12 US$
arrow_upward
+0,16%(+0,060) 1D
38,78 US$
arrow_upward
+1,73% (+0,66)todayPre-market
Closed: 14 ოქტ, 16:00:04 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVO...
Open
37,90 US$
High
38,42 US$
Low
37,90 US$
Mkt. cap
130,07 მლრ.
Avg. vol.
13,28 მლნ.
Volume
342,07 ათ.
Dividend
4,71%
Quarterly dividend
0,45 US$
Ex-dividend date
14 აგვ. 2026
P/E ratio
9,72
52-wk high
64,16 US$
52-wk low
35,12 US$
EPS
3,92 US$
Beta
0,75
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
Open
37,90 US$
High
38,42 US$
Low
37,90 US$
Mkt. cap
130,07 მლრ.
Avg. vol.
13,28 მლნ.
Volume
342,07 ათ.
Dividend
4,71%
Quarterly dividend
0,45 US$
Ex-dividend date
14 აგვ. 2026
P/E ratio
9,72
52-wk high
64,16 US$
52-wk low
35,12 US$
EPS
3,92 US$
Beta
0,75
Shares outstanding
3,39 მლრდ.
No. of employees
67 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
3 საათის წინ
Novo Nordisk stock gains 1.12 percent ahead of November 4 results
PR Newswire
·
4 საათის წინ
Singlife Launches Singapore's First Insurer-led Chronic Care Programme for Weight Management with Novo Singapore and HMI Medical
Yahoo Finance
·
15 საათის წინ
Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOმაზიარ მაიკ დუსტარ
Employees66,7 ათ.
Founded1923
HeadquartersBagsværd, დედაქალაქის რეგიონი, დანია
SectorPharmaceutical industry
Websitenovonordisk.com